JAGX .25 ceo statement: According to JAGX CEO Lisa Conte the company asked for an extension instead of doing a reverse split because: "We are focused on two late-stage clinical events in the next approximately 6 to 12 months that we expect TO BE TRANSFORMATIONAL IN TERMS OF VALUE CREATION and recognition for Jaguar as we seek to regain compliance."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.